ArticleInternational journal of health geographics2016
Using Gini coefficient to determining optimal cluster reporting sizes for spatial scan statistics.
Article in International journal of health geographics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
74 citing papers in PubMed.
- Spatio-temporal clustering characteristics of hepatitis B in China: an 18-year study.Scientific reports · 2026Article
- Spatiotemporal clusters and dengue hotspots in the Philippines: a nationwide analysis spanning 2017-2024.Frontiers in public health · 2026Article
- Epidemiology, serovar distribution and spatiotemporal patterns of Salmonella foodborne infections in Liaoning Province, China, 2014-2024: an analysis of sentinel surveillance data.Frontiers in public health · 2026Article
- Modeling mumps incidence in China: spatiotemporal clusters and evolving risk factors (2005-2020).BMC public health · 2025Article
- Scorpionism in Brazil: Space-time approach and risk areas in 2012 to 2024.PLoS neglected tropical diseases · 2025Article
- Self-reported prevalence of tuberculosis: unveiling spatial representation in the districts of Tamil Nadu.International health · 2025Article
- Geospatial analysis of cholera outbreak in Lusaka, Zambia, between 2023 and 2024.Tropical medicine and health · 2025Article
- From infectious diseases to chronic diseases: the paradigm shift of spatial epidemiology in disease prevention and control.Frontiers in public health · 2025Review
- Spatiotemporal trends and driving factors of gonorrhea incidence in China: a 20-year analysis (2003-2022).Frontiers in public health · 2025Article
- Chikungunya clusters in the state of Bahia: influence of environmental and social factors.Revista da Sociedade Brasileira de Medicina Tropical · 2025Article
- Oropouche fever outbreak in Brazil: Key factors behind the largest epidemic in history.PloS one · 2025Article
- Surveillance of tuberculosis incidence and mortality through spatio-temporal analysis in Oyo State, Nigeria.PloS one · 2025Article
- Trends, geographic distribution, and disease burden of bipolar disorder in Ecuador (2011-2021): An analysis of hospital discharge data.PloS one · 2025Observational
- Geographical Distribution, Spatial Directional Trends, and Spatio-Temporal Clusters of the First Rapid and Widespread Lumpy Skin Disease Outbreaks in Thailand.Transboundary and emerging diseases · 2025Article
- Article
- Ethnic, geographical and altitude considerations and maternal mortality associated with HELLP syndrome in Ecuador: a population-based cohort study.BMC pregnancy and childbirth · 2024Article
- The COVID-19 pandemic in Brazil: space-time approach of cases, deaths, and vaccination coverage (February 2020 - April 2024).BMC infectious diseases · 2024Article
- International Migration, Refugees, and Spread of Tuberculosis in Brazil: Analysis of Clusters, Trends, and Associated Factors (2010-2021).Tropical medicine and infectious disease · 2024Article
- Geospatial investigations in Colombia reveal variations in the distribution of mood and psychotic disorders.Communications medicine · 2024Article
- Comparing circular and flexibly-shaped scan statistics for disease clustering detection.Frontiers in public health · 2024Article
14 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSpatial and space-time scan statistics are widely used in disease surveillance to identify geographical areas of elevated disease risk and for the early detection of disease outbreaks. With a scan statistic, a scanning window of variable location and size moves across the map to evaluate thousands of overlapping windows as potential clusters, adjusting for the multiple testing. Almost always, the method will find many very similar overlapping clusters, and it is not useful to report all of them. This paper proposes to use the Gini coefficient to help select which of the many overlapping clusters to report.
methodsThe Gini coefficient provides a quick and intuitive way to evaluate the degree of the heterogeneity of the collection of clusters, which is useful to explain how well the cluster collection reveal the underlying true cluster patterns. Using simulation studies and real cancer mortality data, it is compared with the traditional approach for reporting non-overlapping clusters.
resultsThe Gini coefficient can identify a more refined collection of non-overlapping clusters to report. For example, it is able to determine when it makes more sense to report a collection of smaller non-overlapping clusters versus a single large cluster containing all of them. It also fulfils a set of desirable theoretical properties, such as being invariant under a uniform multiplication of the population numbers by the same constant.
conclusionsThe Gini coefficient can be used to determine which set of non-overlapping clusters to report. It has been implemented in the free SaTScan™ software version 9.3 ( www.satscan.org ).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.